Identification of recurrent USP48 and BRAF mutations in Cushing’s disease

Cushing’s disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism. Mutations of the deubiquitinase gene USP8 occur in 35–62% of corticotroph adenomas. However, the major driver mutations in USP8 w...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Nature communications Ročník 9; číslo 1; s. 3171 - 9
Hlavní autoři:	Chen, Jianhua, Jian, Xuemin, Deng, Siyu, Ma, Zengyi, Shou, Xuefei, Shen, Yue, Zhang, Qilin, Song, Zhijian, Li, Zhiqiang, Peng, Hong, Peng, Cheng, Chen, Min, Luo, Cheng, Zhao, Dan, Ye, Zhao, Shen, Ming, Zhang, Yichao, Zhou, Juan, Fahira, Aamir, Wang, Yongfei, Li, Shiqi, Zhang, Zhaoyun, Ye, Hongying, Li, Yiming, Shen, Jiawei, Chen, Hong, Tang, Feng, Yao, Zhenwei, Shi, Zhifeng, Chen, Chunjui, Xie, Lu, Wang, Ye, Fu, Chaowei, Mao, Ying, Zhou, Liangfu, Gao, Daming, Yan, Hai, Zhao, Yao, Huang, Chuanxin, Shi, Yongyong
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 09.08.2018 Nature Publishing Group Nature Portfolio
Témata:	45 45/23 631/208/69 692/163/2743/1459/1740 Adenoma Adenoma - genetics Adrenocorticotropic hormone Adrenocorticotropin (ACTH) Adult Binding Sites CpG Islands Cushing syndrome Cushing's disease DNA Mutational Analysis Female Glucocorticoids Humanities and Social Sciences Humans Male Middle Aged Molecular modelling multidisciplinary Mutants Mutation Nervous system diseases Pathogenesis Phenotype Pituitary Pituitary ACTH Hypersecretion - genetics Pro-Opiomelanocortin - genetics Proopiomelanocortin Proto-Oncogene Proteins B-raf - genetics Science Sequence Analysis, DNA Therapeutic applications Therapeutic targets Transcription Tumor cells Tumors Ubiquitin-Specific Proteases - genetics
ISSN:	2041-1723, 2041-1723
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Cushing’s disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism. Mutations of the deubiquitinase gene USP8 occur in 35–62% of corticotroph adenomas. However, the major driver mutations in USP8 wild-type tumors remain elusive. Here, we report recurrent mutations in the deubiquitinase gene USP48 (predominantly encoding p.M415I or p.M415V; 21/91 subjects) and BRAF (encoding p.V600E; 15/91 subjects) in corticotroph adenomas with wild-type USP8 . Similar to USP8 mutants, both USP48 and BRAF mutants enhance the promoter activity and transcription of the gene encoding proopiomelanocortin (POMC), which is the precursor of ACTH, providing a potential mechanism for ACTH overproduction in corticotroph adenomas. Moreover, primary corticotroph tumor cells harboring BRAF V600E are sensitive to the BRAF inhibitor vemurafenib. Our study thus contributes to the understanding of the molecular mechanism of the pathogenesis of corticotroph adenoma and informs therapeutic targets for this disease. In this study the authors report USP48 and BRAF are frequently mutated in USP8 wild-type corticotroph adenomas, and cause Cushing’s disease mainly through promoting the promoter activity of POMC. Inhibition of BRAF may be a promising therapeutic strategy for the treatment of patients with BRAF-mutated corticotroph adenomas.
AbstractList	Cushing’s disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism. Mutations of the deubiquitinase gene USP8 occur in 35–62% of corticotroph adenomas. However, the major driver mutations in USP8 wild-type tumors remain elusive. Here, we report recurrent mutations in the deubiquitinase gene USP48 (predominantly encoding p.M415I or p.M415V; 21/91 subjects) and BRAF (encoding p.V600E; 15/91 subjects) in corticotroph adenomas with wild-type USP8. Similar to USP8 mutants, both USP48 and BRAF mutants enhance the promoter activity and transcription of the gene encoding proopiomelanocortin (POMC), which is the precursor of ACTH, providing a potential mechanism for ACTH overproduction in corticotroph adenomas. Moreover, primary corticotroph tumor cells harboring BRAF V600E are sensitive to the BRAF inhibitor vemurafenib. Our study thus contributes to the understanding of the molecular mechanism of the pathogenesis of corticotroph adenoma and informs therapeutic targets for this disease.In this study the authors report USP48 and BRAF are frequently mutated in USP8 wild-type corticotroph adenomas, and cause Cushing’s disease mainly through promoting the promoter activity of POMC. Inhibition of BRAF may be a promising therapeutic strategy for the treatment of patients with BRAF-mutated corticotroph adenomas. Cushing’s disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism. Mutations of the deubiquitinase gene USP8 occur in 35–62% of corticotroph adenomas. However, the major driver mutations in USP8 wild-type tumors remain elusive. Here, we report recurrent mutations in the deubiquitinase gene USP48 (predominantly encoding p.M415I or p.M415V; 21/91 subjects) and BRAF (encoding p.V600E; 15/91 subjects) in corticotroph adenomas with wild-type USP8 . Similar to USP8 mutants, both USP48 and BRAF mutants enhance the promoter activity and transcription of the gene encoding proopiomelanocortin (POMC), which is the precursor of ACTH, providing a potential mechanism for ACTH overproduction in corticotroph adenomas. Moreover, primary corticotroph tumor cells harboring BRAF V600E are sensitive to the BRAF inhibitor vemurafenib. Our study thus contributes to the understanding of the molecular mechanism of the pathogenesis of corticotroph adenoma and informs therapeutic targets for this disease. Cushing's disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism. Mutations of the deubiquitinase gene USP8 occur in 35-62% of corticotroph adenomas. However, the major driver mutations in USP8 wild-type tumors remain elusive. Here, we report recurrent mutations in the deubiquitinase gene USP48 (predominantly encoding p.M415I or p.M415V; 21/91 subjects) and BRAF (encoding p.V600E; 15/91 subjects) in corticotroph adenomas with wild-type USP8. Similar to USP8 mutants, both USP48 and BRAF mutants enhance the promoter activity and transcription of the gene encoding proopiomelanocortin (POMC), which is the precursor of ACTH, providing a potential mechanism for ACTH overproduction in corticotroph adenomas. Moreover, primary corticotroph tumor cells harboring BRAF V600E are sensitive to the BRAF inhibitor vemurafenib. Our study thus contributes to the understanding of the molecular mechanism of the pathogenesis of corticotroph adenoma and informs therapeutic targets for this disease.Cushing's disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism. Mutations of the deubiquitinase gene USP8 occur in 35-62% of corticotroph adenomas. However, the major driver mutations in USP8 wild-type tumors remain elusive. Here, we report recurrent mutations in the deubiquitinase gene USP48 (predominantly encoding p.M415I or p.M415V; 21/91 subjects) and BRAF (encoding p.V600E; 15/91 subjects) in corticotroph adenomas with wild-type USP8. Similar to USP8 mutants, both USP48 and BRAF mutants enhance the promoter activity and transcription of the gene encoding proopiomelanocortin (POMC), which is the precursor of ACTH, providing a potential mechanism for ACTH overproduction in corticotroph adenomas. Moreover, primary corticotroph tumor cells harboring BRAF V600E are sensitive to the BRAF inhibitor vemurafenib. Our study thus contributes to the understanding of the molecular mechanism of the pathogenesis of corticotroph adenoma and informs therapeutic targets for this disease. Cushing’s disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism. Mutations of the deubiquitinase gene USP8 occur in 35–62% of corticotroph adenomas. However, the major driver mutations in USP8 wild-type tumors remain elusive. Here, we report recurrent mutations in the deubiquitinase gene USP48 (predominantly encoding p.M415I or p.M415V; 21/91 subjects) and BRAF (encoding p.V600E; 15/91 subjects) in corticotroph adenomas with wild-type USP8 . Similar to USP8 mutants, both USP48 and BRAF mutants enhance the promoter activity and transcription of the gene encoding proopiomelanocortin (POMC), which is the precursor of ACTH, providing a potential mechanism for ACTH overproduction in corticotroph adenomas. Moreover, primary corticotroph tumor cells harboring BRAF V600E are sensitive to the BRAF inhibitor vemurafenib. Our study thus contributes to the understanding of the molecular mechanism of the pathogenesis of corticotroph adenoma and informs therapeutic targets for this disease. In this study the authors report USP48 and BRAF are frequently mutated in USP8 wild-type corticotroph adenomas, and cause Cushing’s disease mainly through promoting the promoter activity of POMC. Inhibition of BRAF may be a promising therapeutic strategy for the treatment of patients with BRAF-mutated corticotroph adenomas. Cushing's disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism. Mutations of the deubiquitinase gene USP8 occur in 35-62% of corticotroph adenomas. However, the major driver mutations in USP8 wild-type tumors remain elusive. Here, we report recurrent mutations in the deubiquitinase gene USP48 (predominantly encoding p.M415I or p.M415V; 21/91 subjects) and BRAF (encoding p.V600E; 15/91 subjects) in corticotroph adenomas with wild-type USP8. Similar to USP8 mutants, both USP48 and BRAF mutants enhance the promoter activity and transcription of the gene encoding proopiomelanocortin (POMC), which is the precursor of ACTH, providing a potential mechanism for ACTH overproduction in corticotroph adenomas. Moreover, primary corticotroph tumor cells harboring BRAF V600E are sensitive to the BRAF inhibitor vemurafenib. Our study thus contributes to the understanding of the molecular mechanism of the pathogenesis of corticotroph adenoma and informs therapeutic targets for this disease. Abstract Cushing’s disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism. Mutations of the deubiquitinase gene USP8 occur in 35–62% of corticotroph adenomas. However, the major driver mutations in USP8 wild-type tumors remain elusive. Here, we report recurrent mutations in the deubiquitinase gene USP48 (predominantly encoding p.M415I or p.M415V; 21/91 subjects) and BRAF (encoding p.V600E; 15/91 subjects) in corticotroph adenomas with wild-type USP8. Similar to USP8 mutants, both USP48 and BRAF mutants enhance the promoter activity and transcription of the gene encoding proopiomelanocortin (POMC), which is the precursor of ACTH, providing a potential mechanism for ACTH overproduction in corticotroph adenomas. Moreover, primary corticotroph tumor cells harboring BRAF V600E are sensitive to the BRAF inhibitor vemurafenib. Our study thus contributes to the understanding of the molecular mechanism of the pathogenesis of corticotroph adenoma and informs therapeutic targets for this disease.
ArticleNumber	3171
Author	Jian, Xuemin Fu, Chaowei Yan, Hai Deng, Siyu Chen, Hong Wang, Yongfei Zhang, Yichao Shi, Yongyong Fahira, Aamir Shen, Jiawei Shou, Xuefei Li, Zhiqiang Shen, Ming Luo, Cheng Zhang, Qilin Song, Zhijian Ye, Hongying Li, Yiming Shi, Zhifeng Xie, Lu Mao, Ying Huang, Chuanxin Shen, Yue Li, Shiqi Zhang, Zhaoyun Gao, Daming Chen, Jianhua Zhao, Dan Ma, Zengyi Zhou, Liangfu Tang, Feng Peng, Hong Wang, Ye Zhou, Juan Peng, Cheng Chen, Min Chen, Chunjui Ye, Zhao Zhao, Yao Yao, Zhenwei
Author_xml	– sequence: 1 givenname: Jianhua orcidid: 0000-0003-0326-3124 surname: Chen fullname: Chen, Jianhua organization: Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Department of Otolaryngology Head and Neck Surgery & Center of Sleep Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital – sequence: 2 givenname: Xuemin surname: Jian fullname: Jian, Xuemin organization: Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Department of Otolaryngology Head and Neck Surgery & Center of Sleep Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital – sequence: 3 givenname: Siyu surname: Deng fullname: Deng, Siyu organization: Shanghai Institute of Immunology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine – sequence: 4 givenname: Zengyi surname: Ma fullname: Ma, Zengyi organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 5 givenname: Xuefei surname: Shou fullname: Shou, Xuefei organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 6 givenname: Yue surname: Shen fullname: Shen, Yue organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 7 givenname: Qilin surname: Zhang fullname: Zhang, Qilin organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 8 givenname: Zhijian surname: Song fullname: Song, Zhijian organization: Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Department of Otolaryngology Head and Neck Surgery & Center of Sleep Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital – sequence: 9 givenname: Zhiqiang orcidid: 0000-0002-0174-9254 surname: Li fullname: Li, Zhiqiang organization: Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Department of Otolaryngology Head and Neck Surgery & Center of Sleep Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital – sequence: 10 givenname: Hong surname: Peng fullname: Peng, Hong organization: Shanghai Institute of Immunology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine – sequence: 11 givenname: Cheng surname: Peng fullname: Peng, Cheng organization: Shanghai Institute of Immunology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine – sequence: 12 givenname: Min surname: Chen fullname: Chen, Min organization: CAS Key Laboratory of Systems Biology, CAS Center for Excellence in Molecular Cell Science, Innovation Center for Cell Signaling Network, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences – sequence: 13 givenname: Cheng orcidid: 0000-0003-3864-8382 surname: Luo fullname: Luo, Cheng organization: Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences – sequence: 14 givenname: Dan surname: Zhao fullname: Zhao, Dan organization: University of Chinese Academy of Sciences, Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences – sequence: 15 givenname: Zhao surname: Ye fullname: Ye, Zhao organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 16 givenname: Ming surname: Shen fullname: Shen, Ming organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 17 givenname: Yichao surname: Zhang fullname: Zhang, Yichao organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 18 givenname: Juan surname: Zhou fullname: Zhou, Juan organization: Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Department of Otolaryngology Head and Neck Surgery & Center of Sleep Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital – sequence: 19 givenname: Aamir surname: Fahira fullname: Fahira, Aamir organization: Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Department of Otolaryngology Head and Neck Surgery & Center of Sleep Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital – sequence: 20 givenname: Yongfei surname: Wang fullname: Wang, Yongfei organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 21 givenname: Shiqi surname: Li fullname: Li, Shiqi organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 22 givenname: Zhaoyun surname: Zhang fullname: Zhang, Zhaoyun organization: Shanghai Pituitary Tumor Center, Department of Endocrinology, Huashan Hospital, Shanghai Medical College, Fudan University – sequence: 23 givenname: Hongying surname: Ye fullname: Ye, Hongying organization: Shanghai Pituitary Tumor Center, Department of Endocrinology, Huashan Hospital, Shanghai Medical College, Fudan University – sequence: 24 givenname: Yiming surname: Li fullname: Li, Yiming organization: Shanghai Pituitary Tumor Center, Department of Endocrinology, Huashan Hospital, Shanghai Medical College, Fudan University – sequence: 25 givenname: Jiawei surname: Shen fullname: Shen, Jiawei organization: Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Department of Otolaryngology Head and Neck Surgery & Center of Sleep Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital – sequence: 26 givenname: Hong surname: Chen fullname: Chen, Hong organization: Shanghai Pituitary Tumor Center, Department of Pathology, Huashan Hospital, Shanghai Medical College, Fudan University – sequence: 27 givenname: Feng surname: Tang fullname: Tang, Feng organization: Shanghai Pituitary Tumor Center, Department of Pathology, Huashan Hospital, Shanghai Medical College, Fudan University – sequence: 28 givenname: Zhenwei surname: Yao fullname: Yao, Zhenwei organization: Shanghai Pituitary Tumor Center, Department of Radiology, Huashan Hospital, Shanghai Medical College, Fudan University – sequence: 29 givenname: Zhifeng surname: Shi fullname: Shi, Zhifeng organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 30 givenname: Chunjui surname: Chen fullname: Chen, Chunjui organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 31 givenname: Lu surname: Xie fullname: Xie, Lu organization: Shanghai Center for Bioinformation Technology (SCBIT), Shanghai Academy of Science and Technology – sequence: 32 givenname: Ye surname: Wang fullname: Wang, Ye organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 33 givenname: Chaowei surname: Fu fullname: Fu, Chaowei organization: Department of Epidemiology, School of Public Health, Fudan University – sequence: 34 givenname: Ying surname: Mao fullname: Mao, Ying organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University, State Key Laboratory of Medical Neurobiology, Institute of Neurosurgery, Shanghai Medical College, Fudan University – sequence: 35 givenname: Liangfu surname: Zhou fullname: Zhou, Liangfu organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University – sequence: 36 givenname: Daming orcidid: 0000-0003-4374-1055 surname: Gao fullname: Gao, Daming organization: CAS Key Laboratory of Systems Biology, CAS Center for Excellence in Molecular Cell Science, Innovation Center for Cell Signaling Network, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences – sequence: 37 givenname: Hai surname: Yan fullname: Yan, Hai organization: Department of Pathology, Preston Robert Tisch Brain Tumor Center, Duke University Medical Center – sequence: 38 givenname: Yao surname: Zhao fullname: Zhao, Yao email: zhaoyaohs@vip.sina.com organization: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai Pituitary Tumor Center, Institute of Neurosurgery, Fudan University, State Key Laboratory of Medical Neurobiology, Institute of Neurosurgery, Shanghai Medical College, Fudan University – sequence: 39 givenname: Chuanxin surname: Huang fullname: Huang, Chuanxin email: huangcx@shsmu.edu.cn organization: Shanghai Institute of Immunology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine – sequence: 40 givenname: Yongyong orcidid: 0000-0003-1710-1505 surname: Shi fullname: Shi, Yongyong email: shiyongyong@gmail.com organization: Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), and the Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Department of Otolaryngology Head and Neck Surgery & Center of Sleep Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Institute of Neuropsychiatric Science and Systems Biological Medicine, Shanghai Jiao Tong University, Department of Psychiatry, First Teaching Hospital of Xinjiang Medical University, The Affiliated Hospital of Qingdao University & The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/30093687$$D View this record in MEDLINE/PubMed
BookMark	eNp9kk1uFDEQhS0URELIBVigltiwafC_PRukMCIwIhKIwNpy29UTj3rsYHcjseMaXI-TYKYTSLIYb2yVv_dUZb_H6CCmCAg9JfglwUy_KpxwqVpMdIsFVaIVD9ARxZy0RFF2cOt8iE5K2eC62IJozh-hQ4bxgkmtjtCHlYc4hj44O4YUm9Q3GdyUc602Xy8-cd3Y6Js3n0_Pmu007qDShNgsp3IZ4vr3z1-l8aGALfAEPeztUODkej9GF2dvvyzft-cf362Wp-etk4yPrVsojZXtnATKO8Y99gDMEegUEV5h3VHptdDaM8U1pZ4oTwUnBFOgPTtGq9nVJ7sxVzlsbf5hkg1mV0h5bWwegxvA0I51veiwI9Zy3BPruXNcA18AiA589Xo9e11N3Ra8q0NnO9wxvXsTw6VZp-9GYi2Y4NXgxbVBTt8mKKPZhuJgGGyENBVDsVZ1EkJkRZ_fQzdpyrE-lKFacKklJnQvhbWkAhPOKvXsdt__Gr751wroGXA5lZKhNy7Mn1fHCIMh2PxNkZlTZGqKzC5FRlQpvSe9cd8rYrOoVDiuIf9ve4_qD6EQ2GA
CitedBy_id	crossref_primary_10_1210_endocr_bqab167 crossref_primary_10_3389_fmed_2025_1629621 crossref_primary_10_3390_cancers13164022 crossref_primary_10_1210_endocr_bqac173 crossref_primary_10_1210_jendso_bvab055 crossref_primary_10_3390_cells11213344 crossref_primary_10_3389_fchem_2019_00592 crossref_primary_10_1038_s41467_020_16052_8 crossref_primary_10_1507_endocrj_EJ24_0309 crossref_primary_10_1111_jne_13148 crossref_primary_10_3390_ijms26094058 crossref_primary_10_1111_cen_14706 crossref_primary_10_1186_s12967_025_06960_y crossref_primary_10_1080_17446651_2020_1802243 crossref_primary_10_1001_jama_2023_11305 crossref_primary_10_1080_17446651_2022_2082942 crossref_primary_10_1159_000500688 crossref_primary_10_1210_jendso_bvae085 crossref_primary_10_3390_medicina59040812 crossref_primary_10_1007_s11102_022_01253_9 crossref_primary_10_1038_s41572_024_00588_w crossref_primary_10_1093_neuonc_noz109 crossref_primary_10_3390_ijms23126824 crossref_primary_10_3390_cancers15020496 crossref_primary_10_1016_j_gim_2022_08_021 crossref_primary_10_1210_endrev_bnaa006 crossref_primary_10_1016_j_gene_2020_144456 crossref_primary_10_1111_bpa_13299 crossref_primary_10_1186_s40478_022_01437_1 crossref_primary_10_3390_cancers12020308 crossref_primary_10_1007_s40619_021_00878_5 crossref_primary_10_1016_j_nec_2019_05_001 crossref_primary_10_1210_clinem_dgac280 crossref_primary_10_3390_cancers15235685 crossref_primary_10_1007_s40619_023_01400_9 crossref_primary_10_1111_cen_15065 crossref_primary_10_3390_ijms241310952 crossref_primary_10_1007_s11102_019_00973_9 crossref_primary_10_1016_j_mce_2025_112598 crossref_primary_10_1016_j_yexcr_2025_114469 crossref_primary_10_3390_cancers11091302 crossref_primary_10_1186_s12902_020_0495_8 crossref_primary_10_1186_s12902_021_00845_z crossref_primary_10_1210_clinem_dgaa853 crossref_primary_10_1016_j_beem_2022_101701 crossref_primary_10_3389_fendo_2019_00785 crossref_primary_10_3390_ijms21239132 crossref_primary_10_2217_ije_2019_0006 crossref_primary_10_1210_endrev_bnac010 crossref_primary_10_1210_clinem_dgae055 crossref_primary_10_3390_jcm8111951 crossref_primary_10_1210_clinem_dgaf269 crossref_primary_10_3389_fendo_2024_1302667 crossref_primary_10_1210_jc_2018_02164 crossref_primary_10_1093_ejendo_lvaf086 crossref_primary_10_3390_ijms242115719 crossref_primary_10_1016_j_trsl_2023_01_002 crossref_primary_10_1210_clinem_dgaa969 crossref_primary_10_3390_biomedicines13040968 crossref_primary_10_1007_s12020_021_02903_x crossref_primary_10_1111_cpr_13444 crossref_primary_10_3390_jcm11040955 crossref_primary_10_3390_cancers15010110 crossref_primary_10_3390_jcm9010030 crossref_primary_10_1159_000539017 crossref_primary_10_1007_s40619_019_00574_5 crossref_primary_10_3390_cancers11111761 crossref_primary_10_1016_j_beem_2020_101418 crossref_primary_10_1210_jendso_bvae064 crossref_primary_10_3389_fendo_2020_596554 crossref_primary_10_1093_neuros_nyab209 crossref_primary_10_1007_s12022_021_09663_4 crossref_primary_10_1016_j_ejmech_2024_116333 crossref_primary_10_36290_neu_2024_027 crossref_primary_10_1007_s11102_023_01308_5 crossref_primary_10_1038_s41467_021_21712_4 crossref_primary_10_3390_jcm14093000 crossref_primary_10_1007_s40265_019_01128_7 crossref_primary_10_1007_s40619_022_01202_5 crossref_primary_10_1159_000514862 crossref_primary_10_1007_s00428_023_03713_4 crossref_primary_10_3389_fendo_2021_657382 crossref_primary_10_1007_s11154_021_09626_4 crossref_primary_10_1016_j_arcmed_2023_102915 crossref_primary_10_1016_j_chembiol_2021_05_012 crossref_primary_10_1042_BST20190527 crossref_primary_10_3389_fendo_2022_1024423 crossref_primary_10_7759_cureus_71058 crossref_primary_10_1016_j_celrep_2025_115584 crossref_primary_10_3390_biomedicines8060148 crossref_primary_10_1186_s40478_020_01067_5 crossref_primary_10_3389_fendo_2019_00290 crossref_primary_10_1186_s40478_025_01938_9 crossref_primary_10_3389_fendo_2021_650791 crossref_primary_10_3390_cancers14153660 crossref_primary_10_1007_s11102_022_01220_4
Cites_doi	10.1038/cr.2016.114 10.1186/1755-8794-3-13 10.1093/nar/gkw1121 10.1007/s12020-013-0129-2 10.1111/j.1365-2265.1994.tb02486.x 10.1074/jbc.M313063200 10.1210/jc.2007-2734 10.1038/cr.2015.53 10.1038/cr.2015.20 10.1038/ng.3166 10.1016/j.cellsig.2005.03.017 10.1016/j.ccr.2004.11.004 10.18632/oncotarget.4856 10.1038/nm.2369 10.1016/j.bbamcr.2014.11.028 10.1016/j.ecl.2014.11.004 10.1016/j.ccr.2004.09.022 10.1016/S2213-8587(17)30326-1 10.1128/MCB.17.10.5946 10.1074/jbc.270.28.16483 10.1038/ng.2868 10.1210/mend.16.7.0863 10.1210/mend-5-9-1301 10.1038/nm.3776 10.1016/S0140-6736(14)61375-1 10.1016/S0092-8674(02)01199-6 10.1128/MCB.17.10.5952 10.1186/s13059-016-0893-4 10.1016/j.ccr.2005.12.022 10.1128/MCB.19.11.7549 10.1038/nature00766 10.1038/nrm1498 10.1107/S0021889892009944 10.1038/nature12477 10.1101/gr.076455.108 10.1200/JCO.2005.08.036 10.1172/JCI60417
ContentType	Journal Article
Copyright	The Author(s) 2018. corrected publication 2023 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2018. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2018
Copyright_xml	– notice: The Author(s) 2018. corrected publication 2023 – notice: 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2018. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2018
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI RC3 SOI 7X8 5PM DOA
DOI	10.1038/s41467-018-05275-5
DatabaseName	Open Access资源_Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest SciTech Premium Collection Technology Collection Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection ProQuest Central ProQuest Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest - Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ: Directory of Open Access Journal (DOAJ)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database CrossRef MEDLINE - Academic MEDLINE Publicly Available Content Database
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2041-1723
EndPage	9
ExternalDocumentID	oai_doaj_org_article_2b3bf5b0c1aa40f1ad4cc48e49ee5bed PMC6085354 30093687 10_1038_s41467_018_05275_5
Genre	Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: the National Key Basic Research Program of China (973 Program) – fundername: ;
GroupedDBID	--- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BAPOH BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX AFFHD CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PKEHL PQEST PQUKI RC3 SOI 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c634t-c97807abc6e24b34d0dee3c1eb715d708b26d8588d374822d17d2541102e2f3
IEDL.DBID	M7P
ISICitedReferencesCount	119
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000441157600006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2041-1723
IngestDate	Mon Nov 10 04:36:08 EST 2025 Tue Nov 04 01:58:51 EST 2025 Thu Oct 02 11:04:26 EDT 2025 Tue Oct 07 06:58:09 EDT 2025 Sat Nov 29 14:44:13 EST 2025 Wed Feb 19 02:33:14 EST 2025 Sat Nov 29 03:37:52 EST 2025 Tue Nov 18 22:25:48 EST 2025 Fri Feb 21 02:39:50 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c634t-c97807abc6e24b34d0dee3c1eb715d708b26d8588d374822d17d2541102e2f3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-0174-9254 0000-0003-1710-1505 0000-0003-0326-3124 0000-0003-3864-8382 0000-0003-4374-1055
OpenAccessLink	https://www.proquest.com/docview/2854686012?pq-origsite=%requestingapplication%
PMID	30093687
PQID	2086250143
PQPubID	546298
PageCount	9
ParticipantIDs	doaj_primary_oai_doaj_org_article_2b3bf5b0c1aa40f1ad4cc48e49ee5bed pubmedcentral_primary_oai_pubmedcentral_nih_gov_6085354 proquest_miscellaneous_2087588116 proquest_journals_2854686012 proquest_journals_2086250143 pubmed_primary_30093687 crossref_citationtrail_10_1038_s41467_018_05275_5 crossref_primary_10_1038_s41467_018_05275_5 springer_journals_10_1038_s41467_018_05275_5
PublicationCentury	2000
PublicationDate	2018-08-09
PublicationDateYYYYMMDD	2018-08-09
PublicationDate_xml	– month: 08 year: 2018 text: 2018-08-09 day: 09
PublicationDecade	2010
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Nature communications
PublicationTitleAbbrev	Nat Commun
PublicationTitleAlternate	Nat Commun
PublicationYear	2018
Publisher	Nature Publishing Group UK Nature Publishing Group Nature Portfolio
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio
References	Melmed (CR1) 2015; 44 Davies (CR15) 2002; 417 Reincke (CR7) 2015; 47 Etxabe, Vazquez (CR4) 1994; 40 Weir, Zhao, Meyerson (CR31) 2004; 6 Brastianos (CR28) 2014; 46 Lacroix (CR5) 2018; 6 Colao, Boscaro, Ferone, Casanueva (CR2) 2014; 47 Biller (CR6) 2008; 93 Wellbrock, Karasarides, Marais (CR29) 2004; 5 Schweitzer, Naumann (CR25) 2015; 1853 Tzimas (CR24) 2006; 18 Song (CR11) 2016; 26 Hu (CR36) 2002; 111 Lacroix, Feelders, Stratakis, Nieman (CR3) 2015; 386 Philips (CR19) 1997; 17 Fukuoka (CR33) 2011; 121 Walser, Ponger, Furano (CR27) 2008; 18 Alexandrov (CR13) 2013; 500 Kaiser (CR9) 2015; 25 Rosenthal, McGranahan, Herrero, Taylor, Swanton (CR12) 2016; 17 Forbes (CR35) 2017; 45 Garnett, Marais (CR32) 2004; 6 Zhan, Desiderio (CR34) 2010; 3 Ma (CR8) 2015; 25 Karalis, Venihaki, Zhao, van Vlerken, Chandras (CR26) 2004; 279 Philips (CR17) 1997; 17 Riebold (CR14) 2015; 21 Beeram, Patnaik, Rowinsky (CR16) 2005; 23 Pan (CR38) 2011; 17 Maira, Martens, Philips, Drouin (CR18) 1999; 19 Boutillier (CR21) 1995; 9 Boutillier, Sassone-Corsi, Loeffler (CR20) 1991; 5 Kovalovsky (CR22) 2002; 16 Laskowski, MacArthur, Moss, Thornton (CR37) 1993; 26 Rapp, Gotz, Albert (CR30) 2006; 9 Karin (CR23) 1995; 270 Huang, Shi, Zhao (CR10) 2015; 6 KP Karalis (5275_CR26) 2004; 279 BM Biller (5275_CR6) 2008; 93 X Zhan (5275_CR34) 2010; 3 JC Walser (5275_CR27) 2008; 18 M Karin (5275_CR23) 1995; 270 X Pan (5275_CR38) 2011; 17 RA Laskowski (5275_CR37) 1993; 26 ZJ Song (5275_CR11) 2016; 26 M Hu (5275_CR36) 2002; 111 LB Alexandrov (5275_CR13) 2013; 500 K Schweitzer (5275_CR25) 2015; 1853 B Weir (5275_CR31) 2004; 6 C Huang (5275_CR10) 2015; 6 S Melmed (5275_CR1) 2015; 44 UR Rapp (5275_CR30) 2006; 9 H Fukuoka (5275_CR33) 2011; 121 SA Forbes (5275_CR35) 2017; 45 M Beeram (5275_CR16) 2005; 23 H Davies (5275_CR15) 2002; 417 PK Brastianos (5275_CR28) 2014; 46 M Reincke (5275_CR7) 2015; 47 R Rosenthal (5275_CR12) 2016; 17 AL Boutillier (5275_CR20) 1991; 5 J Etxabe (5275_CR4) 1994; 40 ZY Ma (5275_CR8) 2015; 25 A Lacroix (5275_CR5) 2018; 6 A Colao (5275_CR2) 2014; 47 C Tzimas (5275_CR24) 2006; 18 A Philips (5275_CR17) 1997; 17 A Lacroix (5275_CR3) 2015; 386 M Maira (5275_CR18) 1999; 19 C Wellbrock (5275_CR29) 2004; 5 A Philips (5275_CR19) 1997; 17 MJ Garnett (5275_CR32) 2004; 6 D Kovalovsky (5275_CR22) 2002; 16 UB Kaiser (5275_CR9) 2015; 25 AL Boutillier (5275_CR21) 1995; 9 M Riebold (5275_CR14) 2015; 21
References_xml	– volume: 26 start-page: 1255 year: 2016 end-page: 1259 ident: CR11 article-title: The genome-wide mutational landscape of pituitary adenomas publication-title: Cell Res. doi: 10.1038/cr.2016.114 – volume: 3 year: 2010 ident: CR34 article-title: Signaling pathway networks mined from human pituitary adenoma proteomics data publication-title: BMC Med. Genomics doi: 10.1186/1755-8794-3-13 – volume: 45 start-page: D777 year: 2017 end-page: D783 ident: CR35 article-title: COSMIC: somatic cancer genetics at high-resolution publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkw1121 – volume: 47 start-page: 9 year: 2014 end-page: 20 ident: CR2 article-title: Managing Cushing’s disease: the state of the art publication-title: Endocrine doi: 10.1007/s12020-013-0129-2 – volume: 40 start-page: 479 year: 1994 end-page: 484 ident: CR4 article-title: Morbidity and mortality in Cushing’s disease: an epidemiological approach publication-title: Clin. Endocrinol. (Oxf.) doi: 10.1111/j.1365-2265.1994.tb02486.x – volume: 279 start-page: 10837 year: 2004 end-page: 10840 ident: CR26 article-title: NF-kappaB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene publication-title: J. Biol. Chem. doi: 10.1074/jbc.M313063200 – volume: 93 start-page: 2454 year: 2008 end-page: 2462 ident: CR6 article-title: Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2007-2734 – volume: 25 start-page: 649 year: 2015 end-page: 650 ident: CR9 article-title: Cushing’s disease: towards precision medicine publication-title: Cell Res. doi: 10.1038/cr.2015.53 – volume: 25 start-page: 306 year: 2015 end-page: 317 ident: CR8 article-title: Recurrent gain-of-function USP8 mutations in Cushing’s disease publication-title: Cell Res. doi: 10.1038/cr.2015.20 – volume: 47 start-page: 31 year: 2015 end-page: 38 ident: CR7 article-title: Mutations in the deubiquitinase gene USP8 cause Cushing’s disease publication-title: Nat. Genet. doi: 10.1038/ng.3166 – volume: 18 start-page: 83 year: 2006 end-page: 92 ident: CR24 article-title: Human ubiquitin specific protease 31 is a deubiquitinating enzyme implicated in activation of nuclear factor-kappaB publication-title: Cell Signal. doi: 10.1016/j.cellsig.2005.03.017 – volume: 6 start-page: 433 year: 2004 end-page: 438 ident: CR31 article-title: Somatic alterations in the human cancer genome publication-title: Cancer Cell doi: 10.1016/j.ccr.2004.11.004 – volume: 6 start-page: 18240 year: 2015 end-page: 18241 ident: CR10 article-title: USP8 mutation in Cushing’s disease publication-title: Oncotarget doi: 10.18632/oncotarget.4856 – volume: 17 start-page: 708 year: 2011 end-page: 714 ident: CR38 article-title: Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer publication-title: Nat. Med. doi: 10.1038/nm.2369 – volume: 1853 start-page: 453 year: 2015 end-page: 469 ident: CR25 article-title: CSN-associated USP48 confers stability to nuclear NF-kappaB/RelA by trimming K48-linked Ub-chains publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbamcr.2014.11.028 – volume: 44 start-page: 1 year: 2015 end-page: 9 ident: CR1 article-title: Pituitary tumors publication-title: Endocrinol. Metab. Clin. North Am. doi: 10.1016/j.ecl.2014.11.004 – volume: 6 start-page: 313 year: 2004 end-page: 319 ident: CR32 article-title: Guilty as charged: B-RAF is a human oncogene publication-title: Cancer Cell doi: 10.1016/j.ccr.2004.09.022 – volume: 6 start-page: 17 year: 2018 end-page: 26 ident: CR5 article-title: Efficacy and safety of once-monthly pasireotide in Cushing’s disease: a 12 month clinical trial publication-title: Lancet Diabetes Endocrinol. doi: 10.1016/S2213-8587(17)30326-1 – volume: 17 start-page: 5946 year: 1997 end-page: 5951 ident: CR17 article-title: Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.17.10.5946 – volume: 270 start-page: 16483 year: 1995 end-page: 16486 ident: CR23 article-title: The regulation of AP-1 activity by mitogen-activated protein kinases publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.28.16483 – volume: 46 start-page: 161 year: 2014 end-page: 165 ident: CR28 article-title: Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas publication-title: Nat. Genet. doi: 10.1038/ng.2868 – volume: 9 start-page: 745 year: 1995 end-page: 755 ident: CR21 article-title: Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: characterization of an AP1 site in exon 1 publication-title: Mol. Endocrinol. – volume: 16 start-page: 1638 year: 2002 end-page: 1651 ident: CR22 article-title: Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways publication-title: Mol. Endocrinol. doi: 10.1210/mend.16.7.0863 – volume: 5 start-page: 1301 year: 1991 end-page: 1310 ident: CR20 article-title: The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cells publication-title: Mol. Endocrinol. doi: 10.1210/mend-5-9-1301 – volume: 21 start-page: 276 year: 2015 end-page: 280 ident: CR14 article-title: A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease publication-title: Nat. Med. doi: 10.1038/nm.3776 – volume: 386 start-page: 913 year: 2015 end-page: 927 ident: CR3 article-title: Cushing’s syndrome publication-title: Lancet doi: 10.1016/S0140-6736(14)61375-1 – volume: 111 start-page: 1041 year: 2002 end-page: 1054 ident: CR36 article-title: Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde publication-title: Cell doi: 10.1016/S0092-8674(02)01199-6 – volume: 17 start-page: 5952 year: 1997 end-page: 5959 ident: CR19 article-title: Antagonism between Nur77 and glucocorticoid receptor for control of transcription publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.17.10.5952 – volume: 17 year: 2016 ident: CR12 article-title: DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution publication-title: Genome Biol. doi: 10.1186/s13059-016-0893-4 – volume: 9 start-page: 9 year: 2006 end-page: 12 ident: CR30 article-title: BuCy RAFs drive cells into MEK addiction publication-title: Cancer Cell doi: 10.1016/j.ccr.2005.12.022 – volume: 19 start-page: 7549 year: 1999 end-page: 7557 ident: CR18 article-title: Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.19.11.7549 – volume: 417 start-page: 949 year: 2002 end-page: 954 ident: CR15 article-title: Mutations of the BRAF gene in human cancer publication-title: Nature doi: 10.1038/nature00766 – volume: 5 start-page: 875 year: 2004 end-page: 885 ident: CR29 article-title: The RAF proteins take centre stage publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm1498 – volume: 26 start-page: 283 year: 1993 end-page: 291 ident: CR37 article-title: PROCHECK: a program to check the stereochemical quality of protein structures publication-title: J. Appl. Crystallogr. doi: 10.1107/S0021889892009944 – volume: 500 start-page: 415 year: 2013 end-page: 421 ident: CR13 article-title: Signatures of mutational processes in human cancer publication-title: Nature doi: 10.1038/nature12477 – volume: 18 start-page: 1403 year: 2008 end-page: 1414 ident: CR27 article-title: CpG dinucleotides and the mutation rate of non-CpG DNA publication-title: Genome Res. doi: 10.1101/gr.076455.108 – volume: 23 start-page: 6771 year: 2005 end-page: 6790 ident: CR16 article-title: Raf: a strategic target for therapeutic development against cancer publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.08.036 – volume: 121 start-page: 4712 year: 2011 end-page: 4721 ident: CR33 article-title: EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas publication-title: J. Clin. Invest. doi: 10.1172/JCI60417 – volume: 279 start-page: 10837 year: 2004 ident: 5275_CR26 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M313063200 – volume: 25 start-page: 649 year: 2015 ident: 5275_CR9 publication-title: Cell Res. doi: 10.1038/cr.2015.53 – volume: 17 start-page: 5952 year: 1997 ident: 5275_CR19 publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.17.10.5952 – volume: 386 start-page: 913 year: 2015 ident: 5275_CR3 publication-title: Lancet doi: 10.1016/S0140-6736(14)61375-1 – volume: 17 year: 2016 ident: 5275_CR12 publication-title: Genome Biol. doi: 10.1186/s13059-016-0893-4 – volume: 417 start-page: 949 year: 2002 ident: 5275_CR15 publication-title: Nature doi: 10.1038/nature00766 – volume: 9 start-page: 745 year: 1995 ident: 5275_CR21 publication-title: Mol. Endocrinol. – volume: 21 start-page: 276 year: 2015 ident: 5275_CR14 publication-title: Nat. Med. doi: 10.1038/nm.3776 – volume: 18 start-page: 83 year: 2006 ident: 5275_CR24 publication-title: Cell Signal. doi: 10.1016/j.cellsig.2005.03.017 – volume: 93 start-page: 2454 year: 2008 ident: 5275_CR6 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2007-2734 – volume: 40 start-page: 479 year: 1994 ident: 5275_CR4 publication-title: Clin. Endocrinol. (Oxf.) doi: 10.1111/j.1365-2265.1994.tb02486.x – volume: 6 start-page: 433 year: 2004 ident: 5275_CR31 publication-title: Cancer Cell doi: 10.1016/j.ccr.2004.11.004 – volume: 6 start-page: 17 year: 2018 ident: 5275_CR5 publication-title: Lancet Diabetes Endocrinol. doi: 10.1016/S2213-8587(17)30326-1 – volume: 26 start-page: 1255 year: 2016 ident: 5275_CR11 publication-title: Cell Res. doi: 10.1038/cr.2016.114 – volume: 16 start-page: 1638 year: 2002 ident: 5275_CR22 publication-title: Mol. Endocrinol. doi: 10.1210/mend.16.7.0863 – volume: 18 start-page: 1403 year: 2008 ident: 5275_CR27 publication-title: Genome Res. doi: 10.1101/gr.076455.108 – volume: 3 year: 2010 ident: 5275_CR34 publication-title: BMC Med. Genomics doi: 10.1186/1755-8794-3-13 – volume: 1853 start-page: 453 year: 2015 ident: 5275_CR25 publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbamcr.2014.11.028 – volume: 111 start-page: 1041 year: 2002 ident: 5275_CR36 publication-title: Cell doi: 10.1016/S0092-8674(02)01199-6 – volume: 5 start-page: 875 year: 2004 ident: 5275_CR29 publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm1498 – volume: 26 start-page: 283 year: 1993 ident: 5275_CR37 publication-title: J. Appl. Crystallogr. doi: 10.1107/S0021889892009944 – volume: 44 start-page: 1 year: 2015 ident: 5275_CR1 publication-title: Endocrinol. Metab. Clin. North Am. doi: 10.1016/j.ecl.2014.11.004 – volume: 19 start-page: 7549 year: 1999 ident: 5275_CR18 publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.19.11.7549 – volume: 5 start-page: 1301 year: 1991 ident: 5275_CR20 publication-title: Mol. Endocrinol. doi: 10.1210/mend-5-9-1301 – volume: 6 start-page: 18240 year: 2015 ident: 5275_CR10 publication-title: Oncotarget doi: 10.18632/oncotarget.4856 – volume: 17 start-page: 708 year: 2011 ident: 5275_CR38 publication-title: Nat. Med. doi: 10.1038/nm.2369 – volume: 17 start-page: 5946 year: 1997 ident: 5275_CR17 publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.17.10.5946 – volume: 6 start-page: 313 year: 2004 ident: 5275_CR32 publication-title: Cancer Cell doi: 10.1016/j.ccr.2004.09.022 – volume: 25 start-page: 306 year: 2015 ident: 5275_CR8 publication-title: Cell Res. doi: 10.1038/cr.2015.20 – volume: 23 start-page: 6771 year: 2005 ident: 5275_CR16 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.08.036 – volume: 47 start-page: 31 year: 2015 ident: 5275_CR7 publication-title: Nat. Genet. doi: 10.1038/ng.3166 – volume: 121 start-page: 4712 year: 2011 ident: 5275_CR33 publication-title: J. Clin. Invest. doi: 10.1172/JCI60417 – volume: 47 start-page: 9 year: 2014 ident: 5275_CR2 publication-title: Endocrine doi: 10.1007/s12020-013-0129-2 – volume: 500 start-page: 415 year: 2013 ident: 5275_CR13 publication-title: Nature doi: 10.1038/nature12477 – volume: 270 start-page: 16483 year: 1995 ident: 5275_CR23 publication-title: J. Biol. Chem. doi: 10.1074/jbc.270.28.16483 – volume: 9 start-page: 9 year: 2006 ident: 5275_CR30 publication-title: Cancer Cell doi: 10.1016/j.ccr.2005.12.022 – volume: 46 start-page: 161 year: 2014 ident: 5275_CR28 publication-title: Nat. Genet. doi: 10.1038/ng.2868 – volume: 45 start-page: D777 year: 2017 ident: 5275_CR35 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkw1121
SSID	ssj0000391844
Score	2.5764608
Snippet	Cushing’s disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and... Cushing's disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and... Abstract Cushing’s disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid...
SourceID	doaj pubmedcentral proquest pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	3171
SubjectTerms	45 45/23 631/208/69 692/163/2743/1459/1740 Adenoma Adenoma - genetics Adrenocorticotropic hormone Adrenocorticotropin (ACTH) Adult Binding Sites CpG Islands Cushing syndrome Cushing's disease DNA Mutational Analysis Female Glucocorticoids Humanities and Social Sciences Humans Male Middle Aged Molecular modelling multidisciplinary Mutants Mutation Nervous system diseases Pathogenesis Phenotype Pituitary Pituitary ACTH Hypersecretion - genetics Pro-Opiomelanocortin - genetics Proopiomelanocortin Proto-Oncogene Proteins B-raf - genetics Science Sequence Analysis, DNA Therapeutic applications Therapeutic targets Transcription Tumor cells Tumors Ubiquitin-Specific Proteases - genetics
SummonAdditionalLinks	– databaseName: DOAJ: Directory of Open Access Journal (DOAJ) dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFA5SKvgi1uvYKhF806GT-5nHtrgISilWoW8ht8EFOys7u0Lf-jf69_wl5jK7drXqi6-TzJD5ck5yLsl3EHpJW5DMN10thOI1F4rUIEyoQyvTRc22oSbzzL5Xx8dwdtaeXCv1lc6EFXrgAtw-tcx2wjaOGMObjhjPneMQeBuCsMGn1TdaPdecqbwGsza6Lny8JdMw2B94XhMaAnUjqBK12NiJMmH_TVbm74clf8mY5o1ocg_dHS1IfFBGvoNuhf4-ul1qSl48QO_K1dtujMXhWYfnKaaeWJjwp9MTDtj0Hh9-OJjg82VJxA942uOjZY5Gfb-8GvCYtnmITidvPh69rceKCbWTjC9ql_iElLFOBsot477xITBHglVEeNWApdKDAPCJdYZST5SPHmI0AWigHXuEtvpZH54gbKQVngH1ygL3RpmWShaSedI5BkJWiKyw024kE081Lb7onNRmoAveOuKtM95aVOjV-p2vhUrjr70P05SseyYa7PwgCocehUP_SzgqtLeaUD3q5qBp8uIyr-HNzSC4hOin0gq9WDdHpUuZFNOH2TJ_IvpZQEgE4nERj_VAWQoSSVAVUhuCs_Enmy399HMm9pbR_mWCV-j1SsR-DuvPSD39H0jtojs060Y6DLOHthbzZXiGtt23xXSYP8_K9QMb_ibm priority: 102 providerName: Directory of Open Access Journals
Title	Identification of recurrent USP48 and BRAF mutations in Cushing’s disease
URI	https://link.springer.com/article/10.1038/s41467-018-05275-5 https://www.ncbi.nlm.nih.gov/pubmed/30093687 https://www.proquest.com/docview/2086250143 https://www.proquest.com/docview/2854686012 https://www.proquest.com/docview/2087588116 https://pubmed.ncbi.nlm.nih.gov/PMC6085354 https://doaj.org/article/2b3bf5b0c1aa40f1ad4cc48e49ee5bed
Volume	9
WOSCitedRecordID	wos000441157600006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: P5Z dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database (ProQuest) customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: M7P dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection (ProQuest) customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: 7X7 dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: BENPR dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2041-1723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000391844 issn: 2041-1723 databaseCode: PIMPY dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RFiQuvEsDZWUkbhA18Tsn1K26AgGrqAVp4RI5tgMrQdJudpG48Tf4e_wSYscbtFB64ZJDxolsz4w9D_sbgCc4k5yYpIoZEzSmTKSxZMrGNuPuomaWYOVxZl-L6VTOZlkeAm5tOFa5XhP9Qm0a7WLkB-6mH5ed-4Cfn53HrmqUy66GEhpbsONQEog_upcPMRaHfi4pDXdlEiIPWupXhiSVccKwYDHb2I88bP9FtubfRyb_yJv67Why838HcgtuBEMUHfaScxuu2PoOXOtLU367C6_6G7xVCOmhpkILF5p3YE7o3WlOJVK1QeOTwwn6surz-S2a1-ho5YNaP7__aFHI_tyD08nx26MXcSi8EGtO6DLWDpZIqFJzi2lJqEmMtUSnthQpMyKRJeZGMimNA6_B2KTCdI5mZ0lgiyuyC9t1U9s9QIqXzBCJjSglNUqoDHNinZVTaSIZjyBdT36hAya5K43xufC5cSKLnmFFx7DCM6xgETwdvjnrETkubT12PB1aOjRt_6JZfCyCcha4JGXFykSnStGkSpWhWlNpaWYtK62JYH_NyiKoeFtg5wx6eMSLyQObI3g8kDvddQkZVdtm5X_RuWsyTbuJuN_L19BR4mJNXIoIxIbkbYxkk1LPP3l8cN6Z0YTRCJ6tZfR3t_49Uw8uH8VDuI692rjTMvuwvVys7CO4qr8u5-1iBFtiJvxTjmBnfDzNT0Y-vDHyGtk9c_aho-Qv3-TvfwFY4jnf
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFL0qBQQb3o9AASPBCqImfsTOAqG2MGo1w6iiReqqlmM7MBJkymQG1B2_wT_wVXwJtvNAA6W7LtjGSRQ75177vs4FeIJzkRGTlDFjnMaU8TQWTNnY5pkv1MwTrALP7IiPx-LgIN9dgR9dLYxPq-x0YlDUZqq9j3zdV_plwpkP-OXR59h3jfLR1a6FRgOLoT3-6ky2-sXOK_d_n2I8eL2_tR23XQVinRE6j7Xn3OGq0JnFtCDUJMZaolNb8JQZnogCZ0YwIYxnZsHYpNw4K8ptk9jikri3noPz7hCBRUgU3O09Op5rXVDaVuYkRKzXNOihJBVxwjBnMVva_UKTgJNOtn8naP4RpQ2b3-Dq_7Vs1-BKe8hGG41UXIcVW92Ai03bzeObMGyqk8vWXYmmJZr5sIMnqkLv9napQKoyaPPtxgB9WjS5CjWaVGhrERx2P799r1Eb2boFe2cwj9uwWk0rexeQygpmiMCGF4IaxVWOM2L9Ca7URLAsgrT71VK3fOu-7cdHGeL-RMgGHtLBQwZ4SBbBs_6Zo4Zt5NS7Nz2C-js9U3i4MJ29l63ikbggRcmKRKdK0aRMlaFaU2Fpbi0rrIlgrQOObNVXLbE3dAP148nDPagieNwPO73kg02qstNFeIUzRUWauoW406C5_1Di_WiZ4BHwJZwvzWR5pJp8CNznmTMRCKMRPO8k4vdn_Xul7p0-i0dwaXv_zUiOdsbD-3AZB4H1WUFrsDqfLewDuKC_zCf17GGQeASHZyspvwBPGYxy
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH4qZREX9iVQwEhwgmgS7zkg1IUR1VSjEQWpp1pO7MBIkCmTGVBv_A3-Cb-HX4LtLGig9NYD1ziJYud7z37b9wCe4ExyYpIyZkzQmDKRxpJpG9uM-0LNLME68MzuifFYHhxkkzX40dXC-LTKTicGRW1mhfeRD3ylH5fOfMCDsk2LmOwMXx59jn0HKR9p7dppNBAZ2eOvznyrX-zuuH_9FOPhq7fbr-O2w0BccEIXceH5d4TOC24xzQk1ibGWFKnNRcqMSGSOuZFMSuNZWjA2qTDOonJbJra4JO6t5-C88JTlIWlw0nt3PO-6pLSt0kmIHNQ06KQklXHCsGAxW9kJQ8OAk065fydr_hGxDRvh8Or_u4TX4Ep7-EabjbRchzVb3YCLTTvO45swaqqWy9aNiWYlmvtwhCewQu_2J1QiXRm09WZziD4tmxyGGk0rtL0Mjryf377XqI143YL9M5jHbVivZpW9C0jznBkisRG5pEYLnWFOrD_ZlQWRjEeQdr9dFS0Pu28H8lGFfAAiVQMV5aCiAlQUi-BZ_8xRw0Jy6t1bHk39nZ5BPFyYzd-rViEpnJO8ZHlSpFrTpEy1oUVBpaWZtSy3JoKNDkSqVWu1wt4ADpSQJw_3AIvgcT_s9JUPQunKzpbhFc5ElWnqFuJOg-z-Q4n3r3EpIhArmF-ZyepINf0QONG5Mx0IoxE876Tj92f9e6XunT6LR3DJCYja2x2P7sNlHGTXJwttwPpivrQP4ELxZTGt5w-D8CM4PFtB-QWNwZUv
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+recurrent+USP48+and+BRAF+mutations+in+Cushing%27s+disease&rft.jtitle=Nature+communications&rft.au=Chen%2C+Jianhua&rft.au=Jian%2C+Xuemin&rft.au=Deng%2C+Siyu&rft.au=Ma%2C+Zengyi&rft.date=2018-08-09&rft.issn=2041-1723&rft.eissn=2041-1723&rft.volume=9&rft.issue=1&rft.spage=3171&rft_id=info:doi/10.1038%2Fs41467-018-05275-5&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon